Filament Health Corp. (FLHLF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - Specialty & Generic industria. La empresa tiene su sede en Burnaby, BC, Canada. El CEO actual es Benjamin Lightburn.
FLHLF tiene fecha de IPO 2021-09-03, 13 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $26.18K.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
